mestios
Stack
Explore
Signin
Entity
Bart Neyns
researcher
Express your sentiment! Sign in!
Entity sentiment
Topics
Opinions
1
Sep 16, 2024, 4:23 PM
UZ Brussel"s breakthrough: 27.3% survival in recurrent brain tumors
Bart Neyns
Johnny Duerinck
UZ Brussel
You've reached the end